MCRB Bull Call Spread Strategy
MCRB (Seres Therapeutics, Inc.), in the Healthcare sector, (Biotechnology industry), listed on NASDAQ.
Seres Therapeutics, Inc., a microbiome therapeutics platform company, engages in developing bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. The company's lead product candidate is the SER-109, an oral microbiome therapeutic candidate that has completed Phase III clinical trial for the treatment of clostridium difficile infection (CDI). It is also developing SER-155, a cultivated bacteria microbiome drug, which is Phase Ib clinical trial to reduce incidences of gastrointestinal infections, bloodstream infections, and graft versus host diseases in immunocompromised patients receiving allogeneic hematopoietic stem cell transplantation and solid organ transplants. In addition, the company engages in the development of SER-287 and SER-301 that are in Phase Ib to treat ulcerative colitis; SER-401 for patients with metastatic melanoma; and SER-262 to treat Clostridioides difficile infection. It has license and collaboration agreements with Nestec Ltd. and Memorial Sloan Kettering Cancer Center. The company was formerly known as Seres Health, Inc. and changed its name to Seres Therapeutics, Inc. in May 2015.
MCRB (Seres Therapeutics, Inc.) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $75.1M, a beta of 0.12 versus the broader market, a 52-week range of 6.53-29.98, average daily share volume of 53K, a public-listing history dating back to 2015, approximately 103 full-time employees. These structural characteristics shape how MCRB stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 0.12 indicates MCRB has historically moved less than the broader market, dampening realized volatility and producing tighter expected-move bands per unit of dollar exposure.
What is a bull call spread on MCRB?
A bull call spread buys an at-the-money call and sells an out-of-the-money call at a higher strike for defined risk and defined reward bounded by the strike width.
Current MCRB snapshot
As of May 15, 2026, spot at $7.69, ATM IV 132.70%, IV rank 29.31%, expected move 38.04%. The bull call spread on MCRB below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 34-day expiry.
Why this bull call spread structure on MCRB specifically: MCRB IV at 132.70% is on the cheap side of its 1-year range, which favors premium-buying structures like a MCRB bull call spread, with a market-implied 1-standard-deviation move of approximately 38.04% (roughly $2.93 on the underlying). The 34-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated MCRB expiries trade a higher absolute premium for lower per-day decay. Position sizing on MCRB should anchor to the underlying notional of $7.69 per share and to the trader's directional view on MCRB stock.
MCRB bull call spread setup
The MCRB bull call spread below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With MCRB near $7.69, the first option leg uses a $7.69 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed MCRB chain at a 34-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 MCRB shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 1 | Call | $7.69 | N/A |
| Sell 1 | Call | $8.07 | N/A |
MCRB bull call spread risk and reward
- Net Premium / Debit
- N/A
- Max Profit (per contract)
- Unbounded
- Max Loss (per contract)
- Unbounded
- Breakeven(s)
- None on modeled curve
- Risk / Reward Ratio
- N/A
Max profit equals strike width minus net debit times 100; max loss equals net debit times 100. Breakeven is long-call strike plus net debit.
MCRB bull call spread payoff curve
Modeled P&L at expiration across a range of underlying prices for the bull call spread on MCRB. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
When traders use bull call spread on MCRB
Bull call spreads on MCRB reduce the cost of a bullish MCRB stock position by selling a higher-strike call; suited to moderate-move theses where price reaches but does not vastly exceed the short strike.
MCRB thesis for this bull call spread
The market-implied 1-standard-deviation range for MCRB extends from approximately $4.76 on the downside to $10.62 on the upside. A MCRB bull call spread caps both the risk and the reward of a bullish position; relative to an outright long call on MCRB, the spread reduces the cost basis but limits the maximum profit to the strike width minus net debit. Current MCRB IV rank near 29.31% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on MCRB at 132.70%. As a Healthcare name, MCRB options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to MCRB-specific events.
MCRB bull call spread positions are structurally moderately bullish; the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. MCRB positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move MCRB alongside the broader basket even when MCRB-specific fundamentals are unchanged. Long-premium structures like a bull call spread on MCRB are particularly exposed to IV-crush risk through scheduled events (earnings, FDA decisions, central-bank meetings) where IV typically contracts post-event regardless of the directional outcome. Always rebuild the position from current MCRB chain quotes before placing a trade.
Frequently asked questions
- What is a bull call spread on MCRB?
- A bull call spread on MCRB is the bull call spread strategy applied to MCRB (stock). The strategy is structurally moderately bullish: A bull call spread buys an at-the-money call and sells an out-of-the-money call at a higher strike for defined risk and defined reward bounded by the strike width. With MCRB stock trading near $7.69, the strikes shown on this page are snapped to the nearest listed MCRB chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
- How are MCRB bull call spread max profit and max loss calculated?
- Max profit equals strike width minus net debit times 100; max loss equals net debit times 100. Breakeven is long-call strike plus net debit. For the MCRB bull call spread priced from the end-of-day chain at a 30-day expiry (ATM IV 132.70%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a MCRB bull call spread?
- The breakeven for the MCRB bull call spread priced on this page is no defined breakeven on the modeled curve at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current MCRB market-implied 1-standard-deviation expected move is approximately 38.04%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a bull call spread on MCRB?
- Bull call spreads on MCRB reduce the cost of a bullish MCRB stock position by selling a higher-strike call; suited to moderate-move theses where price reaches but does not vastly exceed the short strike.
- How does current MCRB implied volatility affect this bull call spread?
- MCRB ATM IV is at 132.70% with IV rank near 29.31%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.